Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortium. Heinzl N, Maritschnegg E, Koziel K, Schilhart-Wallisch C, et al. Oncogene 2023 Jul 4. doi: 10.1038/s41388-023-02758.

Read + Share

Amedeo Smart

Independent Medical Education

Heinzl N, Maritschnegg E, Koziel K, Schilhart-Wallisch C, et al. Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortium. Oncogene 2023 Jul 4. doi: 10.1038/s41388-023-02758.
PMID: 37402882